Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

South African Health Minister To Launch PMTCT Plan
South African Health Minister Aaron Motsoaledi within the next two weeks is expected to launch a plan to address mother-to-child HIV transmission in an effort to reduce infant mortality in the country, The Times reports. The MTCT plan is part of a new health program adopted by President Jacob Zuma"s administration, according to The Times."This is one of the most urgent things I want to (deal with) as the new minister," Motsoaledi said. According to Motsoaledi, a child dies every eight minutes in South Africa, and about 40% of child deaths are related to HIV/AIDS. The plan was developed by the Development Bank of Southern Africa at a July meeting of government and health sector stakeholders. Participants at the meeting also examined maternal deaths and the decrease in life expectancy among young adults because of HIV/AIDS. According to Motsoaledi, these and other issues have been identified as priorities for the Zuma administration if South Africa is to meet targets in the United Nations Millennium Development Goals. They also have been consolidated into a 10-point plan to help the Department of Health focus on urgent issues through 2015."Health and education are the biggest challenges for (the government) and we ought to be doing something drastic," Motsoaledi said, adding, "These are very serious issues in society." The health department"s plan also calls for the revival of the National AIDS Council and says that the government should improve regulation of the private health sector. It also calls for the establishment of a national tuberculosis reference laboratory, a focus on infection rates among women ages 17 to 21 and the improvement of HIV prevention among commercial sex workers (Molele, The Times, 5/25). Don't forget to buy zoloft online no prescription.

Complaints By The Elderly Valuable Information Or Trivialities?
What is done when the elderly lodge complaints about their services? elderly care? Why is it that staff describe complaints made by the elderly as "trivialities"? In two recent studies, Tove Persson, doctoral student at the School of Health Sciences, shows that staff, as well as social services directors in local administrations often trivialize complaints from the elderly, which in turn makes it difficult for the elderly to influence their everyday lives.

generic viagra online


News of the day
Insulin Glargine - European Medicines Agency Update On Safety
The European Medicines Agency"s Committee for Medicinal Products for Human Use (CHMP) has concluded that there is no cause for concern of the risk of cancer for people with diabetes on insulin glargine (Lantus).
Nutrition

Quintiles Consulting Outlines Methods For Re-Balancing Drug Development Risks

Quintiles Consulting released the first in a three-part series of white papers addressing how best to navigate risk in drug development. The first paper, "On the Re-Balancing of Risk to Transform Cost and Productivity in Drug Development," focuses on operational risk. It is available for download at http://www.quintiles.com/consulting. Biopharmaceutical companies are facing unprecedented challenges in their efforts to bring new medicines to market to meet the needs of patients. Drug development costs are soaring - requiring on average nearly $1 billion and 17 years to bring a compound to market. It is well recognized in the industry that traditional cost-cutting and methods to improve productivity have been exhausted. "This new environment calls for novel risk-based solutions," said Adrian McKemey, Quintiles Consulting practice leader for product development and commercialization. "We are applying new business models to help companies rebalance, share and hedge their risk - transforming the traditional approach to development. The new risk-based approaches focus on ways to circumscribe, share, rebalance and hedge drug development risk to transform cost and productivity. "We are seeing risk being evaluated through three distinct lenses - operational risk, portfolio risk and re risk," McKemey said. The models outlined in the paper challenge and redistribute the traditional boundaries of the pharmaceutical business model, i.e., what a pharmaceutical company must own to capture competitive advantage and to grow, and what can be factored out and hedged by partnering with external s. The next paper in this series will focus on portfolio risk mitigation. To receive this paper or to learn more about Quintiles Consulting visit our website at http://www.quintiles.com/consulting. The authors: Adrian McKemey is a Managing Director with Quintiles Global Consulting (QGC) and leads the Product Development and Commercialization Practice. Badhri Srinivasan leads the Enterprise Transformation Unit - an organization dedicated to mining the experiences accumulated over 10,000 clinical trials to identify systematic issues and solutions increased speed and reduce cost and variance in clinical development. Peter Payne leads efforts on assessing, mitigating and pricing asset and clinical development risk to support risk sharing initiatives at the portfolio, operational and re level. About Quintiles Consulting Quintiles Consulting works with pharmaceutical, biotech and medical device companies to maximize potential and minimize risk, from discovery through development and commercialization by providing expert strategic, operational, and technical advice. Building on the global reach and expertise of Quintiles Transnational, Quintiles Consulting practice areas include Product Development and Commercialization, Regulatory and Quality, and Market Access, and Eidetics. Quintiles Consulting has full-time consultants based across the U.S. and Europe to serve its global clients. For more information, please visit http://www.quintiles.com/consulting. Quintiles


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009